The development of catalytic processes that allow the preparation of valuable heterocyclic frameworks from readily prepared starting materials under mild conditions is of widespread importance.^[@cit1]^ A range of enantioselective methods that fulfil these goals has been developed.^[@cit2]^ In recent years the catalytic use of C(1)-ammonium enolates,^[@cit3]^ particularly those using carboxylic acids as starting materials,^[@cit4]^ has been popularized following the intramolecular enantioselective nucleophile-catalyzed aldol lactonization (NCAL) methodology developed by Romo for the synthesis of stereodefined β-lactones.^[@cit5]^ In this area, 5-*exo*-ring closure to prepare the corresponding carbo- and heterocyclic ring systems is commonplace ([Fig. 1a](#fig1){ref-type="fig"}), and this strategy has been applied successfully for the construction of complex molecular targets.^[@cit6]^ To date, only limited isolated examples of this approach for the formation of 6-membered ring systems have been developed,^[@cit7]^ all of which use cinchona alkaloids as catalysts. In previous work we developed an isothiourea-catalyzed^[@cit8],[@cit9]^ 5-*exo*-Michael addition-lactonization approach to 5-membered carbo- and heterocycle synthesis from enone acids ([Fig. 1b](#fig1){ref-type="fig"}).^[@cit10]^ In this manuscript the application of this methodology for the preparation of 6-membered heterocycles is reported for the first time, allowing the synthesis of *cis*-chromenones^[@cit11]^ in up to 99 : 1 dr and 98 : 2 er ([Fig. 1c](#fig1){ref-type="fig"}).

![Summary of ammonium enolate promoted intramolecular catalytic enantioselective carbo- and heterocycle formation.](c6cc10178j-f1){#fig1}

Initial model studies probed the cyclization of enone acid **1** to chromenone **2**, with **1** readily prepared in three steps from 2-hydroxyphenylacetic acid.^[@cit12]^ Treatment of **1** with pivaloyl chloride and i-Pr~2~NEt gave the corresponding mixed anhydride *in situ*, which was subsequently treated with isothiourea catalysts **3** to **6** and evaluated for the proposed cyclization ([Table 1](#tab1){ref-type="table"}, entries 1--4). Achiral DHPB^[@cit13]^ gave the desired *cis*-chromenone **2** in 85% yield and \>99 : 1 dr. Screening of a small range of chiral isothioureas **4--6** indicated the use of tetramisole **4** and its benzannulated counterpart, BTM **5**, showed promising enantioselectivity (∼87 : 13 er, entries 2 and 3). Subsequent optimization through variation of solvent, temperature and base^[@cit12]^ showed that performing the reaction at 0 °C in CHCl~3~ with excess i-Pr~2~NEt (1.5 equiv. for mixed anhydride formation, followed by an additional 2.5 equiv.) gave highest observed dr and er (entries 6**--**9). Lowering the catalyst loading to 5 mol% using tetramisole **4** gave **2** in 85% yield, \>99 : 1 dr and 93 : 7 er, with BTM **5** giving lower conversion and isolated product yield even after extended reaction times (entries 10 and 11).

###### Reaction optimization

  ![](c6cc10178j-u1.jpg){#ugr1}                                                        
  ------------------------------------------ ------------ ------ ---- ----- ---------- ---------
  1[^*d*^](#tab1fnd){ref-type="table-fn"}    **3** (20)   rt     16   85    \>99 : 1   Racemic
  2[^*d*^](#tab1fnd){ref-type="table-fn"}    **4** (20)   rt     16   84    \>99 : 1   87 : 13
  3[^*d*^](#tab1fnd){ref-type="table-fn"}    **5** (20)   rt     16   84    \>99 : 1   13 : 87
  4[^*d*^](#tab1fnd){ref-type="table-fn"}    **6** (20)   rt     16   69    \>99 : 1   57 : 43
  5[^*d*^](#tab1fnd){ref-type="table-fn"}    ---          rt     16   nil   ---        ---
  6[^*e*^](#tab1fne){ref-type="table-fn"}    **5** (20)   rt     16   85    \>99 : 1   7 : 93
  7[^*f*^](#tab1fnf){ref-type="table-fn"}    **5** (20)   rt     16   84    \>99 : 1   7 : 93
  8[^*e*^](#tab1fne){ref-type="table-fn"}    **5** (20)   0      4    87    \>99 : 1   7 : 93
  9[^*e*^](#tab1fne){ref-type="table-fn"}    **5** (20)   --10   16   83    \>99 : 1   6 : 94
  10[^*e*^](#tab1fne){ref-type="table-fn"}   **4** (5)    0      4    85    \>99 : 1   93 : 7
  11[^*e*^](#tab1fne){ref-type="table-fn"}   **5** (5)    0      16   65    \>99 : 1   7 : 93

^*a*^Isolated yield.

^*b*^Measured by ^1^H NMR spectroscopy of crude reaction product.

^*c*^Measured by chiral HPLC (major *cis*-diastereoisomer).

^*d*^CH~2~Cl~2~ (0.1 M).

^*e*^CHCl~3~ (0.1 M).

^*f*^CHCl~3~ (0.05 M).

Further investigation monitored product dr and er with reaction conversion and time ([Table 2](#tab2){ref-type="table"}). These studies indicated the dr of the product remained constant (92 : 8 dr *cis* : *trans*) up to full conversion, but increased to 99 : 1 upon extended reaction times. Furthermore, the er of the major *cis*-product decreased from 99 : 1 er (up to full conversion) to 93 : 7 er with time.^[@cit12]^ These observations are consistent with base catalyzed-epimerization of the minor *trans*-diastereoisomer (4a*S*,10b*S*)-**7** to *ent-cis*-(4a*S*,10b*R*) **2**, resulting in increased product dr but lower product er. Consistent with this epimerization process, treatment of an 80 : 20 mixture of *trans*-**7** : *cis*-**2** with i-Pr~2~NEt gave *cis*-**2** in \>99 : 1 dr.^[@cit14]^

###### Epimerization studies

  ![](c6cc10178j-u2.jpg){#ugr2}                              
  ------------------------------- ------- ----- ------------ ----------------
  1                               31%     0.5   92* *:* *8   99* *:* *1
  2                               63%     1.5   92* *:* *8   98.5* *:* *1.5
  3                               Quant   4.5   92* *:* *8   98* *:* *2
  4                               Quant   16    99* *:* *1   93* *:* *7

^*a*^Measured by ^1^H NMR spectroscopy of crude reaction product.

^*b*^Measured by chiral HPLC (major *cis*-diastereoisomer).

To circumvent product epimerization and maximize product er incorporation of an acidic aqueous work-up protocol was essential. For example, carrying the reaction out at 0 °C, followed by work up with H~2~O at rt gave **2** in 85% yield, \>99 : 1 dr and 93 : 7 er. However, work up with 0.1 M HCl at 0 °C gave **2** in 93 : 7 dr, with purification giving **2** as a single diastereoisomer in 70% yield and 98 : 2 er ([Scheme 1](#sch1){ref-type="fig"}).

![Optimized procedure. ^*a *^Measured by ^1^H NMR spectroscopy of crude reaction product. ^*b *^Measured by chiral HPLC (major *cis*-diastereoisomer).](c6cc10178j-s1){#sch1}

With an optimized protocol established, the generality of this process was investigated ([Table 3](#tab3){ref-type="table"}). The tolerance of this methodology to variation within the enone portion was initially probed, with all starting materials prepared from the corresponding 2-hydroxy arylacetic acid through *O*-allylation, ozonolysis and Wittig olefination.^[@cit12]^ Using the 0.1 M HCl work up protocol generally high product er and dr was observed.^[@cit15]^ Notable trends within this series showed that incorporation of halogen (4-FC~6~H~4~ **8** and 4-ClC~6~H~4~ **9**) substituents, as well as electron-donating (4-MeOC~6~H~4~ **10** and 4-MeC~6~H~4~ **11**) and 2-naphthyl substituents **15** gave the desired *cis*-chromenones in excellent enantioselectivity (97 : 3 to 98 : 2 er). Incorporation of electron-withdrawing 4-CF~3~C~6~H~4~or 3,5-(CF~3~)~2~C~6~H~3~ substituents was also tolerated, giving **12** with marginally reduced enantioselectivity and **13** in moderate 37% yield. Incorporation of an aliphatic enone led to decreased reactivity, requiring high catalyst loadings (20 mol%) to promote this transformation (29% isolated yield at 46% conversion), giving **14** as a single diastereoisomer in moderate 71 : 29 er.^[@cit16]^ The relative and absolute configuration within **9** was unambiguously confirmed by X-ray crystal structure analysis,^[@cit17]^ with the absolute configuration of all other products assigned by analogy.

###### Reaction scope: variation of enone component

  -------------------------------
  ![](c6cc10178j-u3.jpg){#ugr3}
  -------------------------------

^*a*^Combined isolated yield of diastereoisomers.

^*b*^Isolated yield of major *cis*-diastereoisomer (\>99 : 1 dr).

^*c*^Measured by ^1^H NMR spectroscopy of crude reaction product.

^*d*^Measured by chiral HPLC (major *cis*-diastereoisomer).

The generality of this methodology was further investigated using different substituents within the aromatic tether ([Table 4](#tab4){ref-type="table"}). Variation of the aromatic tether, incorporating substitution with electron-donating (5-Me, 4-OMe), halogen (4-F) and naphthyl groups gave *cis*-chromenones **16--22** with excellent enantioselectivity (95 : 5 to 98 : 2 er). Notably, incorporation of 4-OMe substituents on the aromatic tether (to give **17** and **21**) showed decreased reactivity, with the reaction taking extended reaction times (12--14 h) to reach \>98% conversion, but still proceeded with excellent enantioselectivity.

###### Reaction scope: variation of aromatic tether

  -------------------------------
  ![](c6cc10178j-u4.jpg){#ugr4}
  -------------------------------

^*a*^Combined isolated yield of diastereoisomers.

^*b*^Isolated yield of major diastereoisomer (\>99 : 1 dr).

^*c*^Measured by ^1^H NMR spectroscopy of crude reaction product.

^*d*^Measured by chiral HPLC (major *cis*-diastereoisomer).

^*e*^12--14 h reaction time.

Reaction scale-up and subsequent product derivatization was investigated. On a one-gram scale, complete conversion of **1** to **2** was observed using only 2.5 mol% catalyst within 6 h to give **2** in 86% isolated yield as a single diastereoisomer and 98 : 2 er.

The synthetic utility of the products was then explored through a range of derivatizations ([Scheme 2](#sch2){ref-type="fig"}). Ring-opening of **2** with either methanol, morpholine or benzylamine gave the corresponding *cis*-dihydrobenzopyrans **23--25** in excellent yield, dr and er. Treatment of *cis*-chromenone **2** with Pd/C and H~2~ (1 atm) led to hydrogenation and hydrogenolysis, giving acid **26** in excellent yield. Alternatively, treatment of a recrystallized sample of **2** (\>99 : 1 er) with *m*-CPBA, followed by *p*-TSA, gave the 5-membered lactone^[@cit18]^ **27** in excellent yield and stereocontrol \[96 : 4 dr, \>99 : 1 er\]. Recrystallization from 10% EtOAc in hexane gave **27** in \>99 : 1 dr, \>99 : 1 er and 82% yield. The relative and absolute configuration of **27** was confirmed by single crystal X-ray structure analysis.^[@cit17]^

![Product derivatization. ^*a *^Isolated yield of major diastereoisomer (\>99 : 1 dr). ^*b *^Measured by ^1^H NMR spectroscopy of crude reaction product. ^*c *^Measured by chiral HPLC (major *cis*-diastereoisomer). ^*d*^ Starting material **2** was \>99 : 1 dr and 99 : 1 er.](c6cc10178j-s2){#sch2}

The mechanism of the isothiourea-catalyzed reaction, shown for the cyclization of enone-acid **1** to **2**, is postulated to proceed *via in situ* formation of mixed anhydride **28** ([Scheme 3](#sch3){ref-type="fig"}). Nucleophilic addition of isothiourea **4** to **28** gives acyl isothiouronium ion intermediate **29**, with deprotonation generating (*Z*)-ammonium enolate **30**. Subsequent intramolecular 6-*exo*-trig Michael addition to the tethered enone generates intermediate **31**, with lactonization giving *cis*-chromenone **2** and regenerating the catalyst **4**. A simplistic model to rationalize the observed diastereo- and enantiocontrol utilizes a stabilising n~0~ to σ~C--S~\* interaction^[@cit19]^ between the enolate oxygen and the sulfur of the isothiouronium ion to restrict the conformation of the (*Z*)-enolate,^[@cit20]^ forcing the stereodirecting phenyl substituent to adopt a pseudoaxial orientation to minimize 1,2-strain. Subsequent 6-*exo*-trig Michael addition occurs *anti*- to this stereodirecting group as represented by pre-transition state assembly **32**, with the two-prostereogenic centres along the developing C--C bond adopting a staggered array to minimize non-bonding interactions.

![Proposed mechanism and stereochemical rationale.](c6cc10178j-s3){#sch3}

In conclusion, the catalytic enantioselective synthesis of *cis*-chromenones has been achieved using commercially available tetramisole as a catalyst. This method provides a range of *cis*-chromenone derivatives in high yield with excellent diastereo- and enantiocontrol (up to 99 : 1 dr and 98 : 2 er). On-going studies in this laboratory are focused on further applications of Lewis base organocatalysts in enantioselective catalysis.
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[^1]: †Electronic supplementary information (ESI) available: Experimental procedures; characterization data for novel compounds; ^1^H and ^13^C NMR spectra, HPLC traces,^[@cit12]^ and X-ray crystallographic data files compounds **9** and **27** (CIF). CCDC [1510311](1510311) and [1510312](1510312). For ESI and crystallographic data in CIF or other electronic format see DOI: [10.1039/c6cc10178j](10.1039/c6cc10178j) Click here for additional data file. Click here for additional data file.
